-
1.发明授权Modified release pharmaceutical composition containing Bupropion HCI as active substance 有权制剂用含有盐酸安非他酮作为活性物质的活性成分的受控释放
公开(公告)号：EP1275383B1
公开(公告)日：2004-03-31
申请号：EP02012184.4
申请日：2002-06-03
申请人： Valpharma S.A.
IPC分类号： A61K31/135 , A61K31/137 , A61K9/20 , A61K9/22
CPC分类号： A61K9/2054 , A61K9/2013 , A61K9/2018 , A61K9/209 , A61K31/137
-
2.发明授权Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance 失效对于含有硝苯地平作为活性物质的口服给药的药物的控制释放组合物
公开(公告)号：EP0838218B1
公开(公告)日：2003-06-25
申请号：EP97116153.4
申请日：1997-09-17
申请人： Valpharma S.A.
发明人： Valducci, Roberto
CPC分类号： A61K9/2027 , A61K9/146 , A61K9/2054 , A61K9/2846 , A61K9/5078 , A61K31/4422
-
3.发明公开Multiparticulate formulations of lithium salts for once-a-day administration 审中-公开MultipartikuläreFormulierungen von Lithiumsalzen zur einmaltäglichenVerabreichung
公开(公告)号：EP1228763A1
公开(公告)日：2002-08-07
申请号：EP02002523.5
申请日：2002-02-03
申请人： Valpharma S.A.
CPC分类号： A61K33/00 , A61K9/2866 , A61K9/5026 , A61K9/5042 , A61K9/5047 , A61K9/5084 , Y10S514/951 , Y10S514/964
摘要： This invention refers to:
multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional release granules, suitable for once-a-day administration also at high strengths of Lithium salts,
and to the preparation process of said formulations.摘要翻译： 本发明涉及：用于口服给药的锂盐的多微粒制剂，其由改性释放颗粒或改性和常规释放颗粒的混合物组成，适用于锂盐的高强度下也适用于一天一次的施用，以及制备方法 所述制剂。
-
公开(公告)号：EP2219618A2
公开(公告)日：2010-08-25
申请号：EP08846855.8
申请日：2008-11-07
申请人： Valpharma S.A.
CPC分类号： A61K9/2826 , A61K9/2027 , A61K9/2086 , A61K9/284 , A61K9/2846 , A61K9/2853 , A61K9/2886 , A61K31/44
摘要： The present invention relates to pharmaceutical formulations comprising a layer of compressed granules to facilitate the administration of oral PPI.
-
5.发明公开Modified release pharmaceutical composition containing Bupropion HCI as active substance 有权安慰剂安非他酮盐酸盐Wirkstoff
公开(公告)号：EP1275383A1
公开(公告)日：2003-01-15
申请号：EP02012184.4
申请日：2002-06-03
申请人： Valpharma S.A.
IPC分类号： A61K31/135 , A61K31/137 , A61K9/20
CPC分类号： A61K9/2054 , A61K9/2013 , A61K9/2018 , A61K9/209 , A61K31/137
摘要： Pharmaceutical composition in modified release tablet form containing Bupropion HCI as active substance and including, at the same time, hydrophilic components and hydrophobic ingredients mixed with an excipient substance.
摘要翻译： 含有作为活性物质的安非他酮的改性释放片形式的药物组合物，同时包括与赋形剂物质混合的亲水组分和疏水性成分。
-
6.发明公开
公开(公告)号：EP0820703A1
公开(公告)日：1998-01-28
申请号：EP97112421.9
申请日：1997-07-21
申请人： Valpharma S.A.
发明人： Valducci, Roberto
CPC分类号： A61K9/5084 , A23L33/15 , A23L33/155 , A23V2002/00 , A61K9/2054 , A61K9/209 , A61K9/4808 , A61K9/5078 , A23V2250/708 , A23V2250/704 , A23V2250/70 , A23V2250/51086 , A23V2250/5118 , A23V2250/628 , A23V2250/1578 , A23V2250/705 , A23V2200/22 , A23V2250/15 , A23V2250/204 , A23V2250/712 , A23V2250/211 , A23V2250/612 , A23V2250/71 , A23V2250/1628 , A23V2250/718 , A23V2250/7106
摘要： The present invention regards compositions for nutritional integration comprising hydrosoluble vitamins having a prolonged-release formulation and liposoluble vitamins having a fast-release formulation, possibly mixed with mineral substances or other nutritional principles.
摘要翻译： 本发明的组合物方面为营养集成，包括具有延长释放制剂具有快速释放制剂，可能与矿物质或其它营养原则混合水溶性维生素和脂溶性维生素。
-
7.发明公开USE OF THE OPIOID ANTAGONIST NALTREXONE TO PREVENT AND CONTROL SIDE EFFECTS CAUSED BY OPIOIDS 审中-公开阿片受体拮抗剂纳曲酮对预防和副作用控制由阿片类药物使用
公开(公告)号：EP1395260A1
公开(公告)日：2004-03-10
申请号：EP02726358.1
申请日：2002-05-02
申请人： Valpharma S.A.
IPC分类号： A61K31/485 , A61P25/04 , A61K9/16 , A61K9/48
CPC分类号： A61K9/1676 , A61K9/4808 , A61K31/485
摘要： Use of naltrexone to prepare pharmaceutical compositions suitable to prevent and control the side effects caused by the treatment with morphine, to be administered by mouth in the dose ranging between 0,01 and 0,9 mg/mg of administered morphine.
-
8.发明公开Multiparticulate enteric coated and multiparticulate enteric coated prolonged release formulations containing NADH 审中-公开NADH-Haltigemultipartikuläredarmlöslichbeschichtete Arzneizusammensetzungen mitverzögerterWirkstoffabgabe
公开(公告)号：EP1346723A1
公开(公告)日：2003-09-24
申请号：EP03005037.1
申请日：2003-03-06
申请人： Valpharma S.A.
CPC分类号： A61K9/5078 , A61K31/70
摘要： Formulations for the oral administration of NADH in multiparticulate enteric coated form and/or dosed either into gelatine capsules or sachets or dispensers.
摘要翻译： 口服多巴胺肠溶包衣形式的NADH的口服给药和/或配制成明胶胶囊或小药囊或分配器的制剂。
-
9.发明公开
公开(公告)号：EP1928424A2
公开(公告)日：2008-06-11
申请号：EP06819063.6
申请日：2006-09-29
申请人： Valpharma S.A.
IPC分类号： A61K9/16 , A61K31/137 , A61K9/48
CPC分类号： A61K9/5078 , A61K9/167 , A61K9/5015 , A61K9/5042 , A61K31/137
摘要： Herein is described a controlled release pharmaceutical composition of venlafaxine hydrochloride, an effective antidepressant, comprising an inert core, on which the active principle is uniformly layered, that in turn is coated with a layer comprising a hardening agent and a lipophilic agent; the process for the preparation of said pharmaceutical composition is also described.
-
10.发明公开Use of chloroquine, hydroxychloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards hiv sensitive strains and towards hiv strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhibitors 审中-公开氯喹，羟氯喹和4- Aminoquinolinderivaten的用作抗HIV菌株和抗性HIV病毒株具有抗性的核苷和非核苷逆转录酶抑制剂和蛋白酶抑制剂的抗逆转录病毒疗法的药物
公开(公告)号：EP1374867A1
公开(公告)日：2004-01-02
申请号：EP03013823.4
申请日：2003-06-18
申请人： Valpharma S.A.
IPC分类号： A61K31/4706 , A61P31/18
CPC分类号： A61K31/4706 , Y02A50/411
摘要： Use of at least one 4 amino-quinolinic derivative to obtain a drug for the anti-retroviral therapy, especially in the therapy of the HIV disease-infection caused by retroviral strains, which are sensitive and/or resistant to known therapies.
Said 4 amino-quinolinic derivative is chloroquine and/or hydroxychloroquine and the drug can be orally administered once or several times a day.摘要翻译： 至少一个4氨基喹啉衍生物的使用，以获得药物为抗逆转录病毒疗法，在HIV疾病感染逆转录病毒株引起的，哪些是敏感和/或以已知的治疗性的治疗中特别爱。 所述4氨基喹啉衍生物是氯喹和/或羟和药物可在一天口服给药一次或数次。
-
-
-
-
-
-
-
-
-
搜索结果
14 条记录 (耗时 0.009 秒)
